The US FDA has green lit ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 in children weighing at least ...

Hearing aids probably cause a large improvement in the ability of adults with mild to moderate hearing loss to take part in everyday life and to listen to other people. They may slightly improve ...

Researchers say this trait is critical for protecting an aging brain. One study found that treating it can slow cognitive ...

Smokers more likely to quit by vaping than other alternatives, study finds - Researchers found that vape use led to 61% ...

The study average sits at 502 points, serving as the dividing line between automakers whose tech execution delights owners ...

For centuries, people have looked for unusual animal behaviour and other signs that might foretell an earthquake. But despite ...

Millions of Americans face persistent challenges in accessing affordable hearing aids, a situation exacerbated by the absence ...

Carmakers keep loading new cars with driver aids, but a surprising share of owners never turn the fanciest ones on ...

In an automotive landscape increasingly dominated by screen overload, driver-facing monitors, and overly complex menus, ...

Giving IV iron to patients with anaemia before heart surgery cuts the need for blood transfusions and time in hospital, say ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced that the U.S. Food and Drug Administration (FDA) has approved Tivicay PD ...